NASDAQ:WBAWalgreens Boots Alliance Stock Price, Forecast & News

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, WBA shares have decreased by 9.9% and is now trading at $41.52.
View which stocks have been most impacted by Coronavirus.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating and 14 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Walgreens Boots Alliance.

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Monday, October 26th 2020.
View our earnings forecast for Walgreens Boots Alliance.

Walgreens Boots Alliance Inc (NASDAQ:WBA) posted its earnings results on Thursday, July, 9th. The pharmacy operator reported $0.83 EPS for the quarter, missing the consensus estimate of $1.10 by $0.27. The pharmacy operator had revenue of $34.63 billion for the quarter, compared to analyst estimates of $34.32 billion. Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. Walgreens Boots Alliance's revenue for the quarter was up .1% on a year-over-year basis. During the same period in the previous year, the business posted $1.47 EPS.
View Walgreens Boots Alliance's earnings history.

Walgreens Boots Alliance declared a quarterly dividend on Thursday, July 9th. Stockholders of record on Wednesday, August 19th will be paid a dividend of $0.4675 per share on Friday, September 11th. This represents a $1.87 annualized dividend and a dividend yield of 4.50%. The ex-dividend date is Tuesday, August 18th. This is an increase from Walgreens Boots Alliance's previous quarterly dividend of $0.46.
View Walgreens Boots Alliance's dividend history.

Walgreens Boots Alliance issued an update on its FY20 earnings guidance on Thursday, July, 9th. The company provided EPS guidance of $4.65-4.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.49.

15 equities research analysts have issued 12-month target prices for Walgreens Boots Alliance's shares. Their forecasts range from $38.00 to $61.00. On average, they anticipate Walgreens Boots Alliance's share price to reach $46.29 in the next twelve months. This suggests a possible upside of 11.5% from the stock's current price.
View analysts' price targets for Walgreens Boots Alliance.

News coverage about WBA stock has been trending very positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Walgreens Boots Alliance earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media stories about the pharmacy operator a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about Walgreens Boots Alliance.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), CVS Health (CVS), Intel (INTC), Walt Disney (DIS), Johnson & Johnson (JNJ), General Electric (GE), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV) and Exxon Mobil (XOM).

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance's stock is owned by many different retail and institutional investors. Top institutional shareholders include LSV Asset Management (1.11%), Thornburg Investment Management Inc. (0.67%), Sumitomo Mitsui Trust Holdings Inc. (0.50%), Swiss National Bank (0.34%), ProShare Advisors LLC (0.31%) and First Trust Advisors LP (0.23%). Company insiders that own Walgreens Boots Alliance stock include Kathleen Wilson-Thompson, Kimberly R Scardino, Marco Patrick Anthony Pagni, Nancy M Schlichting, Ornella Barra and William C Foote.
View institutional ownership trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., State of Michigan Retirement System, Cullen Capital Management LLC, Victory Capital Management Inc., Raymond James & Associates, New York State Common Retirement Fund, QV Investors Inc., and DAVENPORT & Co LLC.
View insider buying and selling activity for Walgreens Boots Alliance.

WBA stock was acquired by a variety of institutional investors in the last quarter, including Unigestion Holding SA, Sumitomo Mitsui Trust Holdings Inc., Mn Services Vermogensbeheer B.V., First Trust Advisors LP, Russell Investments Group Ltd., PGGM Investments, Raymond James Financial Services Advisors Inc., and Robeco Institutional Asset Management B.V..
View insider buying and selling activity for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $41.52.

Walgreens Boots Alliance has a market capitalization of $35.98 billion and generates $136.87 billion in revenue each year. The pharmacy operator earns $3.98 billion in net income (profit) each year or $5.99 on an earnings per share basis. Walgreens Boots Alliance employs 342,000 workers across the globe.

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]